ClinicalTrials.gov record
Completed Phase 3 Interventional

Combination Chemotherapy in Treating Patients With Bladder Cancer

ClinicalTrials.gov ID: NCT00003701

Public ClinicalTrials.gov record NCT00003701. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 6:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Trial of Either M-VAC or Paclitaxel + Carboplatin as Postoperative Adjuvant Therapy in Patients With Muscle-Invasive Transitional Cell Carcinoma of the Bladder at High-Risk for Relapse

Study identification

NCT ID
NCT00003701
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eastern Cooperative Oncology Group
Network
Enrollment
490 participants

Conditions and interventions

Interventions

  • carboplatin Drug
  • cisplatin Drug
  • doxorubicin hydrochloride Drug
  • methotrexate Drug
  • paclitaxel Drug
  • vinblastine sulfate Drug

Drug

Eligibility (public fields only)

Age range
0 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 1999
Primary completion
Jul 31, 2001
Completion
Jun 14, 2007
Last update posted
Jun 14, 2023

1999 – 2007

United States locations

U.S. sites
13
U.S. states
7
U.S. cities
12
Facility City State ZIP Site status
Veterans Affairs Medical Center - Atlanta (Decatur) Decatur Georgia 30033
Indiana University Hospitals Indianapolis Indiana 46202
Hunterdon Regional Cancer Center Flemington New Jersey 08822
Hackensack University Medical Center Hackensack New Jersey 07601
South Jersey Hospital - Millville Millville New Jersey 08332
Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County Mount Holly New Jersey 08060
Riverview Medical Center Red Bank New Jersey 07701
Overlook Hospital Summit New Jersey 07902-0220
Veterans Affairs Medical Center - New York New York New York 10010
NYU School of Medicine's Kaplan Comprehensive Cancer Center New York New York 10016
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Hahnemann University Hospital Philadelphia Pennsylvania 19102-1192
Vanderbilt Cancer Center Nashville Tennessee 37232-6838

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003701, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2023 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003701 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →